Trials / Conditions / Adrenoleukodystrophy (ALD)
Adrenoleukodystrophy (ALD)
3 registered clinical trials studyying Adrenoleukodystrophy (ALD).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Prod NCT02698579 | Genetix Biotherapeutics Inc. | — |
| Terminated | Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD) NCT02204904 | Genetix Biotherapeutics Inc. | — |
| Completed | Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders NCT01043640 | Masonic Cancer Center, University of Minnesota | Phase 2 |